Some people also mention nausea, headaches, dizziness, tiredness, or sleep changes
Symptoms can include chest pain, heart palpitations, and shortness of breath, while electrocardiogram (ECG) changes like tall, "peaked" T waves and a wide QRS complex may be seen
the indications have different doses of the same drug
No claim is made regarding the diagnosis, treatment, cure or prevention of any disease
Lilly is studying retatrutide in several Phase 3 clinical trials to evaluate its potential efficacy and safety in obesity and overweight with at least one weight-related medical problem, type 2 diabetes, knee osteoarthritis, moderate-to-severe obstructive sleep apnea, chronic low back pain, cardiovascular and renal outcomes, and metabolic dysfunction-associated steatotic liver disease
Significant between-study heterogeneity ( I 2 = 709 %, P = 0002) was reduced by subgrouping by study location, treatment duration and type of control (Table 2)